Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sopharma AD Earnings Release 2023

Jan 22, 2024

2543_rns_2024-01-22_36188bfe-9be6-4ca7-8f4d-bc586f9d0fd0.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Current report № 3/ 2024 Dated January 22, 2024

NOTIFICATION

"Sopharma" AD (the Company) notifies that for December 2023 the Company recorded a decrease in sales of 57% compared to the same month of the previous year, incl. 27% decrease in domestic sales and 68% decrease in export sales.

For 2023 the revenues from sales of products increase by 7%, incl. 1% increase of sales for the domestic market and 11% increase in export sales.

Ognian Donev